NCT05387863Recruiting
Decision Aid (DA) for Renal Patients
Evaluation of a Decision Aid in the Treatment Planning of Small Renal Tumors
Source: ClinicalTrials.gov · Last updated 2 Dec 2025
Brief summary (registry, in English)
The objective of this study is to understand how patients make decisions about treating their kidney masses, and to identify key values and preferences for treating their kidney masses. The study team will develop a decision aid (DA) using the decision-analytic model to communicate personalized benefit/harm estimates to patients and promote patient-centered treatment of renal tumors.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 19 May 2022
- Start date
- 12 Sept 2022
- Primary completion date
- Jun 2026
- Lead sponsor
- NYU Langone Health
- Diseases
- Kidney cancer
- NCT number
- NCT05387863
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 12 Sept 2022 to the primary completion date, Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Stage IV cancer of any type
Other
- Inability to provide informed consent
- Vulnerable subjects will not be recruited
Who the study is looking for
- Male and female post-op and pre-op patients, ages 18 and older, diagnosed with a localized renal tumor up to 4 cm in diameter.
- Patients scheduled for standard-of-care clinical exams with the NYU Urology Department
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| NYU Langone Health Coordinator of this site? Confirm its status | New York | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.